Here's How Much You Would Have Made Owning Krystal Biotech Stock In The Last 5 Years
Portfolio Pulse from Benzinga Insights
Krystal Biotech (NASDAQ:KRYS) has significantly outperformed the market over the past 5 years, with an average annual return of 34.07%. A $100 investment in KRYS 5 years ago would now be worth $441.29, highlighting the power of compounded returns.
September 12, 2024 | 8:01 pm
News sentiment analysis
Sort by:
Descending
POSITIVE IMPACT
Krystal Biotech has delivered an impressive 34.07% average annual return over the past 5 years, significantly outperforming the market. This highlights the company's strong growth and the impact of compounded returns.
The article highlights Krystal Biotech's strong performance over the past 5 years, with a significant annualized return that outpaces the market. This positive historical performance is likely to boost investor confidence and could lead to a short-term positive impact on the stock price.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100